Valuable markers for contrast-induced nephropathy in patients undergoing cardiac catheterization

Koji Kato1, Naoki Sato, Takeshi Yamamoto

  • 1Intensive and Cardiac Care Unit, Department of Internal Medicine, Nippon Medical School, Tokyo, Japan. katokoji@nms.ac.jp

Insights

Serum cystatin C effectively predicts contrast-induced nephropathy (CIN) before cardiac catheterization. Elevated cystatin C levels indicate a higher risk of developing CIN, aiding in early detection and management.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Chemistry

Background:

  • Contrast-induced nephropathy (CIN) is a common complication following cardiac catheterization.
  • Early detection and prediction of CIN are crucial for patient management.

Purpose of the Study:

  • To evaluate the predictive utility of pre-catheterization cystatin C for CIN.
  • To establish a diagnostic cut-off level for cystatin C in predicting CIN.
  • To compare cystatin C with other biomarkers for CIN detection.

Main Methods:

  • Prospective study of 87 patients undergoing elective cardiac catheterization.
  • Measurement of cystatin C, creatinine, urinary L-FABP, alpha1, beta2 microglobulins, and N-acetyl-beta-D-glucosaminidase before and after catheterization.
  • Receiver-operating characteristic (ROC) analysis to assess diagnostic performance.

Main Results:

  • Cystatin C demonstrated a higher area-under-the-curve (0.933) than serum creatinine (0.832) in predicting CIN (p=0.012).
  • A cystatin C cut-off level of >1.2 mg/L showed 94.7% sensitivity and 84.8% specificity for CIN detection.
  • Pre-catheterization cystatin C levels were significantly higher in patients who developed CIN (1.36±0.28 mg/L) compared to those who did not (1.08±0.22 mg/L; p=0.007).
  • Urinary L-FABP indicated transient renotubular damage in patients with moderate renal disease.

Conclusions:

  • Pre-catheterization cystatin C is a valuable predictor of CIN.
  • Cystatin C offers superior diagnostic performance compared to serum creatinine for CIN prediction.
  • Urinary L-FABP serves as an indicator of transient renotubular injury.
Abstract

Related Concept Videos

Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Imaging Studies for Cardiovascular System V: CT01:28

Imaging Studies for Cardiovascular System V: CT

Cardiac computed tomography (CT) scanning is an advanced cardiac imaging technique that utilizes CT technology, with or without intravenous (IV) contrast, to produce accurate cross-sectional virtual slices of specific areas of the heart, coronary circulation, and major blood vessels such as the aorta, pulmonary veins, and arteries. The computer processes these slices to generate three-dimensional images. Multidetector CT (MDCT) is a rapid form of CT scanning that captures multiple slices...